x
ServiziMenu principaleHome
You are here: Home > Events > Past events > 2015 > 12th ESO Colorectal Cancer Observatory: innovation and care in the next 12 months
Print

12th ESO Colorectal Cancer Observatory: innovation and care in the next 12 months

Not eligible for ESCO credits

01.07.2015

Barcelona, Spain

COURSES AND SEMINARS

Colon/colorectal cancer

Description

Chair: M. Dicato, LU
Co-chair: J. Gore-Booth, UK 

 

A satellite symposium
held
in conjunction with the
ESMO 17th World Congress
on Gastrointestinal Cancer
 

   

 

The European School of Oncology is pleased to announce the 12th edition of "The ESO Colorectal Cancer Observatory: innovation and care in the next 12 months", which will be held during the 17th World Congress on Gastrointestinal Cancer on July 1-4 in Barcelona, chaired by Prof. Dicato. The scope of the session is to provide the participants with a take home message on what they can expect to happen in the colorectal cancer field in the next 12 months.


In collaboration with: 

 
 
 
 
 


 

 

General information


ESO SECRETARIAT

Daniela Mengato
European School of Oncology
Via Turati 29
20121, Milan, Italy
dmengato@eso.net


VENUE
Centre de Convencions Internacional de Barcelona (CCIB)
Rambla de Prim 1-17
08019 Barcelona
Spain
18:45 - 20:15
Room 116



ATTENDANCE
Attendance is granted to all participants registered to the ESMO 17th World Congress on Gastrointestinal Cancer.


CONCLUSION
The conclusion of the Observatory will be made available on the ESO website.


.



.

Faculty list


FACULTY
N. Arber, The Tel-Aviv Sourasky Medical Center, Tel-Aviv, IL
M. Dicato
, Centre Hospitalier de Luxembourg, LU
J. Gore-Booth
, EuropaColon, London, UK
N. Howie, Charity Runner Neil, UK/RS
R. Labianca, Ospedali Riuniti di Bergamo, IT
B. Nordlinger, Hopital Ambroise Paré, Boulogne-Billancourt, FR
J. Tabernero, Hospital Vall D'Hebron, Barcelona, ES

E. Van Cutsem, University Hospital Gasthuisberg, Leuven, BE

Programme


TOPICS
Screening of colorectal cancer
N. Arber, IL
Adjuvant therapy of colorectal cancer
R. Labianca, IT
Therapy of metastatic colorectal cancer
E. van Cutsem, BE
New therapies
J. Tabernero, ES
Surgical progress in the treatment of colorectal cancer
B. Nordlinger, FR

The patient’s perspective

N. Howie, UK/RS



Follow us